P A van Zwieten
Overview
Explore the profile of P A van Zwieten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
630
Citations
2460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Milliano P, Tijssen J, van Zwieten P, Lie K
Neth Heart J
. 2015 Feb;
9(8):334-342.
PMID: 25696756
Treatment for heart failure may be directed at relieving symptoms and/or improving prognosis. One of the primary aims of research in heart failure is to alter the progressive decline in...
2.
van Zwieten P
Neth Heart J
. 2015 Feb;
14(9):301-308.
PMID: 25696664
The metabolic syndrome (MBS) is characterised by a clustering of cardiovascular and metabolic risk factors. This syndrome is now widely recognised as a distinct pathological entity, and it is receiving...
3.
4.
van Zwieten P
Neth Heart J
. 2015 Feb;
14(11):381-387.
PMID: 25696573
A survey is presented of the registered non-peptidergic angiotensin II receptor antagonists (AT blockers, ARBs, sartans) and their general properties and similarities. Accordingly, their receptor profile, pharmacokinetic and therapeutic applications...
5.
van Zwieten P
Neth Heart J
. 2015 Feb;
11(12):510-513.
PMID: 25696172
Recently the results of two important large-scale studies on hypertension management were published and intensely debated: ALLHAT and ANBP-2. In particular the ALLHAT study was discussed and subjected to criticism....
6.
7.
van Zwieten P
Neth Heart J
. 2015 Feb;
10(1):19-22.
PMID: 25696028
Isolated systolic hypertension (ISH) is characterised by elevated systolic (SBP) and somewhat lowered diastolic blood pressure (DBP). ISH occurs predominantly in elderly hypertensives as a result of aortic stiffness, which...
8.
9.
Streefkerk J, van Zwieten P
Auton Autacoid Pharmacol
. 2006 Mar;
26(2):141-8.
PMID: 16553642
The present survey deals with the development and applications of non-peptidergic vasopressin receptor antagonists. The existence of at least three vasopressin receptors (V(1), V(2) and V(3) respectively) is firmly established....
10.
Wonnemann M, Schug B, Schmucker K, Brendel E, van Zwieten P, Blume H
Int J Clin Pharmacol Ther
. 2006 Jan;
44(1):38-48.
PMID: 16425970
The objective of this study was to compare the rate and extent of nifedipine bioavailability after single dose administration of Adalat OROS 30 (Reference) and Nifedipine Sandoz retard 30 tablets...